EVALUATION OF ANTI-CANCER ACTIVITY IN METHANOLIC EXTRACT OF ENICOSTEMMA LITTORALE ON DEN INDUCED HEPATOCARCINOGENESIS IN RATS by Abarnadevika Alagiri, Thanga kokila Mookiah, Ariharasivakumar Ganesan, Manisenthil Kumar Thigarajan, Rajasekaran Aiyalu, Arivukkarasu Ramasamy*
 www.iajpr.com 
 
P
ag
e1
5
3
7
 
                                                 Indo American Journal of Pharmaceutical Research, 2018                      ISSN NO: 2231-6876 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EVALUATION OF ANTI-CANCER ACTIVITY IN METHANOLIC EXTRACT OF ENICOSTEMMA 
LITTORALE ON DEN INDUCED HEPATOCARCINOGENESIS IN RATS 
 
Abarnadevika Alagiri, Thanga kokila Mookiah, Ariharasivakumar Ganesan, Manisenthil Kumar 
Thigarajan, Rajasekaran Aiyalu, Arivukkarasu Ramasamy
*
 
KMCH College of Pharmacy, Coimbatore, Tamilnadu, India-641048. 
 
Corresponding author  
Arivukkarasu Ramasamy 
KMCH College of Pharmacy,  
Coimbatore, Tamilnadu,  
India-641048 
phytoarivu@gmail.com 
+917094659909 
 
 
 
 
 
 
 
 
 
 
 
Copy right © 2018 This is an Open Access article distributed under the terms of the Indo American journal of Pharmaceutical 
Research, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
ARTICLE INFO  ABSTRACT 
Article history 
Received 11/03/2018 
Available online 
31/03/2018 
 
Keywords 
Sweroside, 
DEN, 
HPTLC, 
In Vitro Antioxidant. 
 
 The present study is aimed at evaluating the chemoprotective effect of Enicostemma littorale 
in DEN induced hepato-carcinogenesis in Sprague Dawley rats. The preliminary steps 
involved extraction, phytochemical investigation, HPTLC study and In vitro antioxidant 
activity using DPPH, ABTS. and Initiation of HCC was done by single i.p injection of DEN 
at a dose of 200mg/kg.  The MEEL received treatment for 90 days after 14 days of 
development of HCC and continued for entire study period, whereas the other two group 
given normal saline, 5-flurouracil (20mg/kg ) i.p. The results showed that the injection DEN 
lead to the development of liver tumors in rats. Significant effect of serum biochemical 
parameter like SGOT, SGPT, ALP, UREA, TOTAL PROTEIN and tumor marker was 
observed with depletion of endogenous antioxidants SOD, CAT, GSH, there by leading to 
higher LPO.  The result exhibited that MEEL treatment (Preventive) group offered excellent 
shielding against HCC and displayed all the parameter in near normal range with a 
maintained antioxidant enzyme system. The result obtained showed that extracts were found 
to containing phenols at a concentration of 70.25 mg/g and flavonoids 26.03mg/g.  HPTLC 
Analysis showed presence of Quercetin, Mangiferin, Gallic acid, Catechin and sweroside. In 
the DPPH, ABTS, FRAP, TRAP radical scavenging assay MEEL has displayed the highest 
antiradical activity in both assays and was also comparable with the standard qucertein The  
present study reveal the efficacy of the MEEL to prevent malignancy induced by chemical 
carcinogen and the phytoconstituents responsible for activity.   
Please cite this article in press as Arivukkarasu Ramasamy et al. Evaluation of Anti-Cancer Activity in Methanolic Extract of 
Enicostemma Littorale on Den Induced Hepatocarcinogenesis in Rats. Indo American Journal of Pharmaceutical Research. 
2018:8(03). 
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INTRODUCTION 
Cancer is a group of many related diseases that begin in cells, the body’s basic unit of life.  Normally, cell grow and divide to 
produce more cells only when the body needs them.  Sometimes, however, cells become abnormal and keep dividing to form more 
cells without control or order, creating a mass of excess tissue called a tumor.  Tumors can be malignant (cancerous) or benign (non 
cancerous).  Cancer is a group of disease involving abnormal cell growth with the potential to invade (or) spread to other part of the 
body.  It result from variation in normal mechanism governing cell behavior [1]
 
Hepatocellular carcinoma (HCC) is the most common 
type of primary liver cancer and is the most common cause of death in people with cirrhosis.  It occurs in the setting of chronic liver 
inflammation, and is most closely linked to chronic viral hepatitis infection (or) exposure to toxin such as alcohol. They are either 
primary when the cancer starts in itself, or metastatic, when the cancer has spread to liver from some other part of the body[2] 
Enicostemma littorale Blume (E. littorale) plays a vital role in human healthcare. The plant parts of E. littorale such as leaves, roots 
were used in traditional practice for treating several ailments like malaria, skin diseases, leprosy, diabetes etc.  The leaf possesses 
hypoglycemic, antioxidant, hepatoprotective and hepatomodulatory properties and helps in reducing obesity[3] DEN (diethyl 
nitrosamine) is a well known hepatocarcinogenic agent, which produces the primary metabolic activation resulting in initiation of liver 
carcinogenesis and formation of liver tumor after repeated administration, is normally used to induce liver cancer in several animal 
models[4].The present study was aimed to evaluate the anti-cancer Activity in methanolic extract of Enicostemma littorale on DEN 
Induced hepatocarcinogenesis in rats and detection and estimation of phytoconstituents responsible for therapeutic efficacy. 
 
 
 
Figure 1: Habitat of Enicostemma littorale Blume. 
 
MATERIALS AND METHODS 
Plant collection, authentication and extraction 
The whole plant Enicostemma littorale were collected from the area of Thirunelveli, Tamilnadu, India.  The plant material 
was authenticated by Dr.P.Sathiyarajeswaran, Director, Plant Anatomy Research Centre, Chennai, Tamilnadu, India and a voucher 
specimen no: E18020901L of the whole plant.  Dried and coarse powder of Enicostemma littorale (400g) were extracted successively 
using methanol as a solvent, it was extracted in Soxhle.  Extract was concentrated to dryness in rotary evaporator under reduced 
pressure to yield a dark brown mass of methanolic extract of Enicostemma littorale (MEEL) plant.  The obtained crude extract was 
weighed and stored. The percentage of yield - 38.3 %. 
 
Preliminary phytochemical analysis 
A portion of extract was subjected to preliminary phytochemical analysis to confirm the presence of carbohydrates, alkaloids, 
flavonoids, phenols, proteins, aminoacids, tannins and steroids[5]. 
 
Quantification of Total Phenolics and Flavonoids 
Estimation of Total Phenolics 
The total phenolic content of the extract was determined by Folin-Ciocalteau assay method[6]. To an aliquot 100μl of extract 
(or standard solution of Gallic acid (10, 20, 40, 60, 80, 100μg/ml) added 50μl of Folin-Ciocalteau reagent followed by 860μl of 
distilled water and the mixture is incubated for 5min at room temperature. 100μl of 20% sodium carbonate and 890μl of distilled water 
were added to make the final solution to 2ml. It was incubated for 30min in dark to complete the reaction. The absorbance of the 
mixture was measured at 725nm against blank.  Distilled water was used as reagent blank. The tests were performed in triplicate to get 
mean the values. The total phenolic content was found out from the calibration curve of Gallic acid and it was conveyed as milligrams 
of Gallic acid equivalents (GAE) per gram of extract. 
 
Estimation of Total Flavonoids  
The total flavonoid content of the MEEL was determined by using Aluminium chloride colorimetric method[7]. To an aliquot 
of 100μl of extract or standard solutions of Quercetin (10, 20, 40, 60, 80, 100μg/ml), methanol was added separately to make up the 
solution upto 2ml. The resulting mixture was treated with 0.1ml of 10% aluminium chloride, 0.1ml of 1M potassium acetate and 2.8ml 
of distilled water. Shaken well and incubated at room temperature for 30minutes. The absorbance was measured at 415nm against 
blank, where a solution of 2ml ethanol, 0.1ml potassium acetate, 2.8ml distilled water and 0.1ml of aluminium chloride serve as blank 
solution. The total flavonoid content was determined from the standard Quercetin calibration curve and it was expressed as milligrams 
of Quercetin equivalents (QE) per gram of extract. 
                                                   
www.iajpr.com 
P
ag
e1
5
3
9
 
Vol 8 Issue 03, 2018.                                                Arivukkarasu Ramasamy et al.                                            ISSN NO: 2231-6876 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
High Performance Thin Layer Chromatography  
Preparation of standard and sample  
HPTLC was used for the qualitative and quantitative phytochemical study of herbal drugs. Stock solutions of standard 
compounds were prepared by dissolving accurately weighed 1mg of Gallic acid, Rutin, Quercetin, Maniferin, and Galiicacid  in 1ml 
of methanol (HPTLC grade). Samples were prepared by accurately weighed 1g of Enicostemma littorale and dissolved separately in 
10ml methanol. Each sample was then filtered by using Whatmann No.1 filter paper. 
 
Application of sample  
The sample solution were spotted in the form of bands of width 6mm with a Hamilton 100µl syringe on percolated plate 60 
F254 ( 10 cm  10 cm with 0.2 mm thickness ) using a camag Linomat V applicator. The slit dimension was kept 6 mm  0.45 mm. 
10µl of each sample and 5µl of standard solutions were applied on to the plate . 
 
Development  
The chromatogram was development in Camag glass twin throught chamber (10  10 cm ) previously saturated with the 
mobile phase Toluene: Ethyl acetate: Formic acid: Methanol (3:6:1.6:0.4) mobile phase was used for quantification of flavonids and 
mobile phase of ethyl acetate: methanol: water (7.7:1.5:0.5) was used for quantification of sweroside[8]. The migration distance was 
80 mm TLC plate were air dried with air dryer. Densitometry scanning was performed using Camag TLC Scanner III at 254 nm and 
366 nm operated by a wincat software.  
 
Detection  
The plate was scanned at UV 254 nm using Camag TLC Scanner- III.  Rf value of each compound which were separated on 
plate and data of peak area of each band was recorded . 
 
In vitro antioxidant studies 
DPPH radical scavenging assay 
The antioxidant activity of the extract was measured in terms of hydrogen donating or radical scavenging ability, using the 
DPPH method. 0.1mM solution of DPPH in methanol was prepared and 1ml of this solution was added to 1ml of various 
concentrations of sample and the reference compound (10, 20, 30, 40 and 50µg/ml).  The mixture was shaken vigorously and left to 
stand in the dark at room temperature for 30 min. Then the absorbance was measured at 517nm against a blank.  Reference compound 
used was ascorbic acid.  A control reaction was carried out without the test sample [9]
. 
The percentage of inhibition was calculated by 
comparing the absorbance values of the control and test samples. Antiradical activity was expressed as percentage inhibition (I%) and 
calculated using the following equation: 
 
Percentage2 inhibition (I %) = (Abs control - Abs sample /Abs control) X 100 
 
ABTS radical cation assay 
ABTS radical scavenging activity of the extract was measured by the method. ABTS was dissolved in water to a 7mM 
concentration. ABTS radical cation (ABTS+) was produced by reacting ABTS stock solution with 2.45mM potassium persulfate and 
allowing the mixture to stand in the dark at room temperature for 12 - 16h before use.  For the study, ABTS solution was diluted with 
phosphate buffer saline pH 7.4 (PBS) to an absorbance of 0.70 (± 0.02) at 734nm and equilibrated at 300ºC[10]
.
After addition of 2ml 
of diluted ABTS
+
 solution to 20µl of various concentrations of sample or reference compound (ascorbic acid), the reaction mixture 
was incubated for 6min and then absorbance was measured at 734nm against a blank.  A control reaction was carried out without the 
sample. The percentage inhibition of ABTS
+
 by the sample was calculated according to the formula:  
 
Percentage inhibition (I%) = (Abs control - Abs sample /Abs control) X 100. 
 
Ferric reducing anti-oxidant power assay (FRAP) 
The basic principle involved in the assay is the reduction of the ferric complex of Fe(TPTZ)
3+ 
i.e: tripyridyltriazine (a ferroin 
analogue) to Fe(TPTZ)
2+ 
complex (intensely blue in colour) in the presence of anti-oxidant in an acidic pH. There will be an increase 
in absorbance value at 593nm [10].  The reagent was prepared by mixing 15.15ml 0.2M acetate buffer (pH 3.6), 1.5ml of 20mMol 
TPTZ, 1.5ml of 20mMol ferric chloride and 1.9ml of distilled water.  The sample /standard compounds were taken in different 
concentrations of (20,40,60,80 and 100µg/ml) and mixed with 0.9ml of the reagent.  Absorbance of the mixture was measured 
spectrophotometrically at 595nm after 30minutes of incubation. Vitamin-C was used as standard. The experiment was done in 
duplicate and parallel blank was also prepared excluding the sample/standard compound. 
 
Total reducing antioxidant power assay (TRAP) 
The reagent was prepared by mixing 5ml DCF (2,7-dichloroflurescein acetate) of, 20ml of PBS (Sodium phosphate buffer 
saline), 25ml of NaOH. The sample /standard compounds were taken in different concentrations of (20,40,60,80 and 100 µg/ml) and 
mixed with 0.9ml of the reagent.  Absorbance of the mixture was measured spectrophotometrically at 490nm after 30 minutes of 
incubation[10]. Vitamin-C was used as standard. The experiment was done in duplicate and parallel blank was also prepared 
excluding the sample/standard compound. 
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Pharmacological study 
Experimental animals 
Sprague Dawley Male rat weight of animals was 150-200gm. The animals were housed under controlled conditions of 
temperature (20-25
0
C) and photoperiod 12-h light/dark cycle. All animal procedures were performed after approval from the animal 
ethical committee and accordance with the recommendations for the proper care and use of laboratory animals[11-14].  
 
Screening of anti-cancer activity of MEEL  
Group 1 - Normal (Normal saline)  
Group 2- DEN Control  
Group 3- DEN + Standard  [5 Flurouracil (20 mg/kg) body wt i.p)] 
Group 4- DEN + MEEL (Low dose – 250 mg/kg p.o)  
Group 5- DEN + MEEL (High dose – 500 mg/kg p.o) 
 
Estimation of haematological parameters 
Blood collection 
After the end of the treatment period (90 days) the animals were anaesthetized with ketamine (i.p) and its blood was collected 
by retro orbital puncture with addition of EDTA for the enumeration of blood cells i.e., RBC and WBC. The estimation of various 
biochemical parameters carried out by using blood sample without adding EDTA. 
 
Separation of Serum 
For the estimation of the biochemical parameters such as Alkaline phosphatase (ALP), Serum glutamate oxalo acetate 
transaminase (SGOT), Serum glutamate pyruvate transaminase (SGPT), Serum creatinine and total protein, the serum was separated 
from the blood by centrifuging at 5000 rpm for 15 minutes.The separated serum was collected and used for the estimation of 
parameters. 
 
Evaluation of Antioxidant Parameters 
A 10% homogenate of liver tissue was used to analysis  enzymatic antioxidant activity like superoxide dismutase( SOD) 
Catalase(CAT), and non enzymatic anti oxidant activity reduced glutathione activity (GSH), and lipid peroxidation (LPO) were also 
estimated[15-16]. 
 
Histopathological studies 
 The liver from all groups were removed rapidly, and thoroughly rinsed with ice-cold saline. After 24hr of fixation followed 
by embedding in a paraffin block, it was cut into sections of 5µ onto a glass slide and stained with hematoxylin-eosin for histological 
assessment of the tissue. Sections of liver were examined by light microscope at 10X and 40X magnification[17].
 
 
Statistical analysis 
 The data’s of all the parameters were analyzed using the Graph pad 5.0 software. Analysis of Variance (ANOVA); one way 
ANOVA followed by Tukey multiple comparison test was performed. The values were expressed as Mean ± SEM. 
 
RESULT AND DISSCUSION  
Preliminary phytochemical analysis 
 From the phytochemical results shows the presence of Carbohydrates, Glycosides, Alkaloids, Phenolics, Flavonoids, 
Tannins, Triterpenoids, Saponins, Steroids, Proteins and amino acids in the formulation.  
 
Estimation of Total Phenol and Flavanoids in MEEL 
The preliminary phytochemical analysis showed the presence of phenols and flavonoids in plant extract which are considered 
as potent antioxidants. The total phenol and flavonoids was determined by UV spectrophotometric method. The result obtained 
showed that extracts were found to containing phenols at a concentration of 70.25 mg/g and flavonoids 26.03mg/g. 
 
High Performance Thin Layer Chromatography : 
The following different solvent compositions were tried for monitoring the elution of components in the plant extract of 
Enicostemma litrolle. Toluene: Ethyl acetate: Formic acid: Methanol (3:6:1.6:0.4) were used for quantification of flavonids in the 
extract and Ethyl acetate: methanol: water (7.7:1.5:0.5) were used for quantification of sweroside and the respective Rf values of 
flavanoids was found to be Quercetin 0.84, Mangiferin 0.26, Gallic acid 0.74, Catechin 0.74, and for sweroside 0.49 
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     Figure 2: Chromatogram of extract and flavonoid standard                          Figure 3: Chromatogram of extract and                                                                                                                                                                                                                                                                
standard sweroside marker                                                                                          markers. 
 
1. Quercetin (5µl , 2.MEEL (10µl)                                                              1. MEEL (5µl), 2. MEEL (10µl) 3. MEEL (20µl  
3. Rutin (5µl) 4.Mangiferin (5µl)                                                               4. Sweroside (20µl) 
5.Galli acid (5µl), 6. Catachin (5µl) 
 
                                                                                                       
 
Table 1: Quantification of flavonoids and sweroside in MEEL. 
 
Extract Volume 
applied µl 
Percentage of 
 Quercetin 
Percentage of 
mangiferin 
Percentage of 
Gallic acid 
Percentage 
of Catechin 
Percentage of  
sweroside 
MEEL 5µl    1.076%      0.15%      0.35%         0.56%         1.20% 
 
In vitro Antioxidant Activity  
The methanolic extract of Enicostemma littorle was compared with standard markers to evaluate their antioxidant capacity 
using DPPH photometric assay, ABTS radical scavenging activity, Ferric reducing ability (FRAP) and TRAP. Table 2 indicates the 
IC50 values of standard and the MEEL. The methanolic extract of Enicostemma littorle exhibited significant free radical scavenging 
activity of ABTS.  
 
Table 2: Antioxidant potential of standard and Methanolic extract of Enicostemma littorale. 
 
Assay IC50 value 
 Standard Sample 
ABTS (Quercetin) 0.2013 13.44 
DPPH (Quercetin) 5.981 33.74 
FRAP (Quercetin) 28.17 48.64 
TRAP (Quercetin) 16.81 49.63 
 
PHARMACOLOGICAL ACTIVITY  
Haematological parameters 
The results of hematological investigation show the disease control group has shown a significant reduction in RBC and 
WBC. The MEEL preventive group as well as treatment group has shown a significant increase of RBC. Table 3 indicate siginificant 
difference between the treated and control group . 
 
Effect of Body weight and liver weight analysis   
The results revealed that the body weights were significantly decreased in DEN treated group. However, extract treatment 
showed significant protection in body weight when compared to DEN control group. Standard drug also significantly increased the 
body weight than the DEN treated animals but no significant difference was observed between extract treated animals and standard 
treated animals. (Table 4). Liver weight were significantly increased in DEN control group. However, extract treatment group are 
showing significant production in liver weight .whereas , Standard drug show significant reduction in relative liver weight compared 
to DEN control group. (Table 5). 
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Serum biochemical parameters 
Serum biochemical parameters clearly evident that DEN treatment group caused significant elevation of liver serum markers. 
DEN treated group, the level of AST, ALP, ALT, Urea, Creatinine were significantly elevated. The extract treatment was able to 
reverse all the elevated serum biochemical parameter near to normal and the results were comparable to that of standard treated group. 
(Table 6). 
 
Invivo antioxidant studies 
Administration of DEN induced control group increase in the level of lipid peroxidation and decrease in catalase, superoxide 
dismutase, glutathione peroxidase and glutathione S- transferase levels in liver homogenate The MEEL preventive group manifested 
remarkable increase in their level which was extremely significant even more than that observed with standard group. (Table 7). 
 
Table 3: Effect of MEEL on the RBC& WBC counts. 
 
Groups  Normal  Control  Standard  MEEL Low dose MEEL High dose 
RBC 
 
9.48 
±0.18  
5.81 
±0.21***  
8.78 
±0.07***  
7.45 
±0.12***  
6.73 
±0.08**  
WBC 
 
6.57 
±0.06  
5.25 
±0.15***  
6.59 
±0.12***  
5.81 
±0.06**  
5.30 
±0.05
ns 
 
Data is expressed as mean ± SEM (n = 6 animal in each group). 
*** - P˂0.001, **-P˂0.001,*- P˂0.05, ns- non Significant. 
 
Table 4: Effect of MEEL on the Body weight of the Experimental rats. 
 
Weight in gram Normal Control Standard MEEL Low dose MEEL High dose 
Initial body weight 
145.7  
± 5.5 
182.5 
±6.3*** 
129.3 
±5.2*** 
139.2 
±4.9*** 
149.5 
±3.4** 
Final body weight 
192.3 
±4.8 
167.2 
±4.0** 
185.3 
±3.5** 
196 
±4.5*** 
      205 
±5.9** 
Data is expressed as mean ± SEM ( n = 6 animal in each group). 
*** - P˂0.001, **-P˂0.001,*- P˂0.05, ns- non Significant. 
 
Liver weight analysis 
 
Table 5: Effect of the MEEL on the Liver weight of the Experimental rats. 
 
GROUP  Normal  Control  Standard  MEEL Low dose  MEEL High dose  
Liver weight in gm 8.23 
±0.23  
9.58 
±0.17***  
8.13 
±0.21***  
7.83 
±0.18**  
7.03 
±0.26**  
Data is expressed as mean ± SEM (n = 6 animal in each group). 
*** - P˂0.001, **-P˂0.001,*- P˂0.05, ns- non Significant. 
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Table 6: Effect of the MEEL on the Serum biochemical parameters. 
 
GROUP  Normal  Control  Standard  MEEL Low dose  MEEL High dose  
SGOT(U/L)  44.5 
±1.176  
83.67 
±1.282***  
64.67 
±1.054***  
66 
±1.366***  
61 
±1.317**  
SGPT(U/L)    37.5 
±1.893  
87.33 
±2.459***  
60.83 
±1.778**  
74.67 
±1.116**  
69.01 
±1.392**  
ALP(U/L) 
93.5 
±5.847 
163 
±6.593*** 
99.67 
±4.372*** 
138.5 
±2.045* 
135.1 
±2.162** 
UREA 
32.1 
±4.861 
71.65 
±3.593*** 
46.17 
±4.045** 
49.83 
±1.138** 
43.68 
±1.352* 
CREATININE 
(mg/dl) 
0.67 
±0.060 
1.65 
±0.076*** 
0.70 
±0.027*** 
0.73 
±0.044*** 
0.78 
±0.020*** 
PROTEIN 
(g/ml) 
4.38 
±0.252 
7.35 
±0.286*** 
5.84 
±0.120** 
5.48 
±0.310** 
6.93 
±0.188ns 
Data is expressed as mean ± SEM (n = 6 animal in each group). 
*** - P˂0.001, **-P˂0.001,*- P˂0.05, ns- non Significant. 
 
Table 7: Estimation of enzymatic and non enzymatic activity. 
 
Group Normal Control Standard MEEL Low dose MEEL High dose 
SOD 
(U/min/mg/ 
protein ) 
8.04 
±0.358 
2.52 
±0.365*** 
6.63 
±0.435*** 
7.34 
±0.270*** 
6.97 
±0.276** 
CAT 
(µmol of H2  O2 consumed/ min/mg protein ) 
75.97 
±4.499 
35.67 
±4.499** 
69.33 
±2.603*** 
54.17 
±5.839* 
57.17 
±2.971** 
LPO 
(nmol MDA / mg protein) 
1.34 
±0.766 
6.33 
±0.432*** 
4.70 
±0.171* 
4.60 
±0.088ns 
3.77 
±0.197* 
GSH 
(mmoles/mg tissue protein) 
9.37 
±0.308 
3.98 
±0.279***  
8.44 
±0.308**  
6.97 
±0.303**  
6.63 
±0.608*  
Data is expressed as mean ± SEM ( n = 6 animal in each group )  
*** - P˂0.001, **-P˂0.001,*- P˂0.05,  ns- non Significant 
 
ESTIMATION OF HISTOPATHOLOGY 
 
                              
 
      Figure 4 : Normal group showing the no evidence of                    Figure 5 : DEN induced control group showing Portal tract 
                           inflammation and liver fibrosis.                                      portal Inflammation are  present. Parenchymal necrosis 
                                                                                                                                  (Focal lytic necrosis) was also evident . 
 
                       
       
      Figure 6: Standard drug treated group showing Mild                     Figure 7:MEEL treated low dose group showing Portal 
      Portal inflammation No evidence of parenchymal                                tract – Inflammation Present. Hepatic 
                          inflammation / necrosis .                                                           parenchyma – Mild necrosis.             
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Figure 8: MEEL high dose treated group showing Portal inflammation with interface hepatitis .Parenchymal marked inflammation. 
 
DISSCUSION 
This study demonstrate a potential role of methanolic extract of Enicostemma littorale in limiting pre neoplastic changes in 
DEN-initiated experimental hepatocarcinogenesis in rats. The result obtained showed that extracts were found to containing phenols at 
a concentration of 70.25 mg/g and flavonoids 26.03mg/g.  In the present study the HPTLC Analysis revel the presence of Quercetin, 
Mangiferin, Rutin, Gallic acid & Catechin.  Earlier report shows the iridoid glycoside sweroside was isolated from Swertia mileensis 
have antihepatitic activity and sweroside reduced the SGPT level in hepatitis patients after 45 days treatment[18-19]
.
 The effective 
cure rate for acute patients was 84% and that for chronic patients 70%. In the DPPH, ABTS, FRAP, TRAP radical scavenging assay 
MEEL has displayed the highest antiradical activity in both assays and was also comparable with the standard qucertein.  Increase in 
liver weight was observed for the disease control group and the marked reduction of weight was observable in both preventive and 
treated groups of MEEL. Alterations were seen in the hematological parameters in HCC. The disease control group has shown a 
significant reduction in RBC and WBC. The MEEL preventive group as well as treatment group has shown a significant increase of 
RBC. The experimental group showed significant increase in WBC count while the treated group showed moderate reduction in 
WBC. Serum biochemical parameters show an altered pattern in the cancerous condition. The escalation in the activities of plasma 
AST, ALT, and ALP indicated that DEN may prompt hepatic dysfunction. The enzymes directly associated with the conversion of 
amino acids to keto acids are AST and ALT, and are proved to be increased in the HCC condition.  
Serum transaminases, alkaline phosphatases, total bilirubin, creatinine, urea and a tumor marker enzyme alpha feto protein 
were evaluated MEEL treatment group was also very effective in normalizing the SGPT, creatinine and urea level, but only a 
moderately significant reduction was shown for the other parameters. Total Protein present in the liver tissue of disease control group 
was reduced due to the cancerous condition. But in the MEEL preventive group there was a significant increase in the protein levels 
compared to disease control and no noticeable difference when compared to the normal control. MEEL treatment group also exhibited 
significant increase in the protein content, bringing back it to the normal. The impaired liver functions may be due to oxidative stress 
which leads to disturbances in the protective physiological moieties that further leads to lipid peroxidation thus eventually causes 
damage to the macromolecules in vital biomembranes. There was a marked reduction in the activity of enzymatic as well as non-
enzymatic components such as SOD, CAT, *and GSH in the disease control group, while it’s note worthy that the MEEL preventive  
group manifested remarkable increase in their level which was extremely significant even more than that observed with standard 
group. The MEEL treatment group also displayed significant rise in all component levels. The results obtained from the current study 
demonstrate that the MEEL offers a significant protection against hepatocarcinoma and it was very clear that the extract was able to 
prevent malignancy. It was clear that there exists an antioxidants, When the MEEL groups received showed higher shielding in DEN 
induced HCC rat model. When the extract was given for prevention and treatment of cancer, the extract has manifested propitious 
results which may be on account of the additive activity of the phyto molecules present in the extracts. 
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CONCLUSION 
The present study it can be concluded that the Enicostemma littorale Blume has the potential to prevent HCC as well as it can 
reduce the complications of the same. It seems promising that these data obtained from the study can be further validated in the future 
studies which eventually can be developed as a formulation that offers a high degree of protection from HCC. Further study is 
required for the detected compound sweroside and its mechanism of action for anticancer activity and for future use.  
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ABBREVIATION USED  
Abbreviation Full name/ Meaning 
MEEL Methanolic extract of Enicostemma littorale 
HCC Hepatocellular Carinoma 
DEN Diethylnitrosamine 
ROS Reactive Oxygen Species 
GSH Reduced Glutathione 
SOD Superoxide Dimutase  
CAT Catalase 
LPO Lipid Peroxidase  
SGOT Serum Glutamate Oxaloacetate Transminase  
SGPT                                                       Serum Glutamate Pyruvate Transaminase 
p.o Per Oral 
i.p Intra peritoneal  
µl                          Micro Litre 
ml                         Milli Litre  
g Gram 
kg Kilo gram 
ANOVA                     Anaysis of Variance 
SEM Standard Error Mean 
SD Standard Deviation 
ABTS 2,2'-azino-bis(3-ethylbenzothiazoline-6-
sulphonicacid 
DPPH 2,2-diphenyl-1-picrylhydrazyl 
 
REFERENCES  
1. Chuang SC, La Vecchia C, Boffetta P. Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV 
infection .Cancer lett. 2009;286(1) : 9-14 
2. Gurfateh singh, Nancy dhadwal, Harikumar sl Experimen tal models for hepatotoxicity .Asian journal of pharmaceutical and 
clinical research 2015;8,(2),70-74.  
3. Dr.Nidhi Mishra et al., Enicostemma littorale blume review article. Journal of medicinal plant studies 2017;5(1):78-82. 
4. K. Balamurugan et al., Evaluation of Luteolin in the Preventionof N-nitrosodiethylamine-induced Hepatocellular Carcinoma 
Using Animal Model System Ind J Clin Biochem 2012; 27(2):1-2. 
5. Leelaprakash G, Mohan Dass S. Antimicrobial activity and phytochemical screening of methanol extract of Enicostemma 
axillare. Int J Pharm Pharm Sci. 2012;4(1):342–348. 
6. Ragazzi, E,. Veronese G. Quantitative analysis of phenolics compounds after thin–layer chromatographic separation. 
J.Chromatogr. 1973; 77: 369.375.  
7. Zou YP, Lu YH, & Wei DZ. Antioxidant activity of a flavonoid rich extract of Hypericum perforatum L.in vitro. J Agric Food 
Chem .2004;52:5032-5039. 
8. Arivukkarasu R, Rajasekaran A. Detection of Flavonoids, Phenolic Acids and Xanthones in Commercial Herbal Formulations by 
HPTLC Technique. Research Journal of Pharmacognosy and Phytochemistry. 2015; 7(1):13-27. 
9. Akhtar H. Antioxidant potential of dried Enicostemma littorale. Pak Bio Sci. 2011;14(20):956. 
10. Krishnaveni A, Mohandass S. Antioxidant activity of Enicostemma axillare (invitro studies). Journal of pharmacy research. 2012; 
5(8):3954-3956. 
11. Verna L, Whysner J and Williams GM: N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct 
formation, mutagenicity, and tumor initiation. Pharmacol Ther 1996;71(1-2): 57-81. 
                                                   
www.iajpr.com 
P
ag
e1
5
4
6
 
Vol 8 Issue 03, 2018.                                                Arivukkarasu Ramasamy et al.                                            ISSN NO: 2231-6876 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12. Bhatt NM, Barua S, Gupta S. Protective effect of Enicostemma littorale Blume on rat model of diabetic neuropathy. Am J Infect 
Dis. 2009;5(2):99–105. 
13. Gupta S, Dadheech N, Singh A, Soni S, Bhonde RR. Enicostemma littorale: A new therapeutic target for islet of neogenesis. Int J 
Int Bio. 2010;9(1):50-53. 
14. Rajasekaran A, Arivukkarasu R, Murugesh S. Hepatoprotective effect of Adenema hyssopifolium G.Don (Gentianaceae) in carbon 
tetrachloride-induced hepatotoxicity in rats. Trop J Pharm Res. 2010;9 (2):157–163. 
15. Thirumalai T, Therasa VS, Elumalai EK, David E. Hypolipidemic and antioxidant effect of Enicostemma littorale Blume. Asian 
Pac J Trop Biomed. 2011;1: 381–385. 
16. Sathiskumar R, Lakshmi PTV, Annamalai A. Comparative analyses of non enzymatic and enzymatic antioxidants of 
Enicostemma littorale Blume. Int J Pharma Bio Sci. 2010; 1(2):1–16. 
17. Janani P, Sivakumari K, Geetha A, Ravisankar B and Parthasarathy C: Chemopreventive effect of bacoside a on n-
nitrosodiethylamine-induced hepatocarcinogenesis in rats. J Cancer Res Clin Oncol 2010; 136:759-770. 
18. He RY and Nie RL. Studies on bitter principles from Swertia mileensis. Acta Botanica yunnanica1980;2:480-82. 
19. Zhou J .some bioactive substances from plants of west china. Pure and Applied Chemistry1989; 61: 457-60.  
 
 
 
 
 
 
 
   
54878478451180304 
 
 
 
 
 
 
 
 
 
 
 
 
 
